The many breakthroughs in HIV have not been matched with the shift in financing perspective that is required by a disease with chronic as well as infectious characteristics, with the attendant financial and ethical burden that this entails.read full post
Member of the RethinkHIV consortium, Sir Paul Collier, Professor of Economics and Public Policy at the Blavatnik School of Government, Oxford University, has been awarded the British Academy President’s Medal. The award recognizes Prof Collier’s pioneering contribution in bringing ideas from research into policy within the field of African economics. Read more about the medal here: http://www.bsg.ox.ac.uk/news/prof-paul-collier-awarded-british-academy-presidentread full post
RethinkHIV is a consortium of senior researchers from London School of Hygiene & Tropical Medicine, Imperial College London, Harvard School of Public Health, Centre for the Study of African Economies and Blavatnik School of Government at Oxford University.
The consortium will evaluate new evidence related to the costs, benefits, effects, fiscal implications, and developmental impacts of HIV interventions in sub-Saharan Africa, in order to maximise contributions to the fight against HIV there.
The aim of RethinkHIV is to find ways of creating, optimising, and sustaining fiscal space for domestic HIV investment, as well as exploring long-term, sustainable national and international financing mechanisms. RethinkHIV is funded by RUSH Foundation.